Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy.
barriers
direct acting antivirals
eradication
primary care
proactive case-finding
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
18 Dec 2020
18 Dec 2020
Historique:
received:
25
11
2020
revised:
14
12
2020
accepted:
15
12
2020
entrez:
23
12
2020
pubmed:
24
12
2020
medline:
24
12
2020
Statut:
epublish
Résumé
Hepatitis C virus (HCV) infection remains a pressing public health issue. Our aim is to assess the linkage to care of patients with HCV diagnosis and to support the proactive case-finding of new HCV-infected patients in an Italian primary care setting. This was a retrospective cohort study of 44 general practitioners (GPs) who managed 63,955 inhabitants in the Campania region. Adults with already known HCV diagnosis or those with HCV high-risk profile at June 2019 were identified and reviewed by GPs to identify newly diagnosed of HCV and to assess the linkage to care and treatment for the HCV patients. Overall, 698 HCV patients were identified, 596 with already known HCV diagnosis and 102 identified by testing the high-risk group (2614 subjects). The 38.8% were already treated with direct-acting antivirals, 18.9% were referred to the specialist center and 42.3% were not sent to specialist care for treatment. Similar proportions were found for patients with an already known HCV diagnosis and those newly diagnosed. Given that the HCV infection is often silent, case-finding needs to be proactive and based on risk information. Our findings suggested that there needs to be greater outreach, awareness and education among GPs in order to enhance HCV testing, linkage to care and treatment.
Identifiants
pubmed: 33352991
pii: life10120359
doi: 10.3390/life10120359
pmc: PMC7766029
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Br J Gen Pract. 2014 Feb;64(619):e67-74
pubmed: 24567619
Liver Int. 2019 Oct;39(10):1845-1851
pubmed: 31169953
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
Eur J Gastroenterol Hepatol. 2017 Mar;29(3):271-276
pubmed: 27849644
Minerva Gastroenterol Dietol. 2005 Mar;51(1):31-46
pubmed: 15756144
Eur J Intern Med. 2018 Jul;53:79-84
pubmed: 29475770
Am J Public Health. 2012 Nov;102(11):e115-21
pubmed: 22994166
PLoS One. 2019 Jul 10;14(7):e0219396
pubmed: 31291351
Dig Liver Dis. 2020 May;52(5):541-546
pubmed: 32234417
BMC Infect Dis. 2015 Oct 26;15:471
pubmed: 26503519
Clin Infect Dis. 2013 Jan;56(1):40-50
pubmed: 22990852
J Viral Hepat. 2006 Apr;13(4):264-71
pubmed: 16611193
Dig Liver Dis. 2020 Jul 27;:
pubmed: 32732070
Dig Dis Sci. 2016 Dec;61(12):3460-3468
pubmed: 26957497
Clin Microbiol Infect. 2011 Feb;17(2):107-15
pubmed: 21091831
J Med Econ. 2012;15(5):887-96
pubmed: 22458755
J Clin Transl Hepatol. 2019 Sep 28;7(3):226-231
pubmed: 31608214
Infect Dis (Auckl). 2019 Apr 28;12:1178633719841381
pubmed: 31065216
World J Hepatol. 2018 Feb 27;10(2):319-328
pubmed: 29527267
World J Gastroenterol. 2014 Jul 28;20(28):9270-80
pubmed: 25071320
Dig Liver Dis. 2013 May;45(5):403-7
pubmed: 23199596
JAMA. 2014 Aug 13;312(6):631-40
pubmed: 25117132
J Hepatol. 2016 Oct;65(1 Suppl):S120-S129
pubmed: 27641982
Liver Int. 2020 Feb;40 Suppl 1:67-71
pubmed: 32077601
Dig Liver Dis. 2019 Jul;51(7):915-921
pubmed: 31031174
Liver Int. 2017 Feb;37(2):259-270
pubmed: 27427866